UPS partners with McKesson to transport and deliver the Moderna COVID-19 vaccine
UPS (NYSE:UPS) continues its involvement with COVID-19 vaccine delivery efforts through a partnership with global pharmaceutical and medical supply distributor McKesson. Through contracts with the Centres for Disease Control and Prevention and the Assistant Secretary for Preparedness and Response to support Operation Warp Speed, McKesson is the centralised distributor for non-ultra-frozen COVID-19 vaccines and ancillary supply kits. Under its agreement with McKesson, UPS will begin delivering Moderna's COVID-19 vaccine, which today received a U.S. Food and Drug Administration Emergency Use Authorisation.
"This is a historic logistics feat and UPS Healthcare is honored to play a role in this effort," says Wes Wheeler, president of UPS Healthcare. "Our mantra is 'Quality Focused. Patient Driven' and we know that at the end of each vaccine journey is a patient seeking hope and relief from this pandemic. We take our pivotal role in this ongoing campaign seriously."
UPS Healthcare delivers unparalleled healthcare logistics expertise to its customers around the world. UPS Healthcare has 11+ million square feet of cGMP and GDP-compliant healthcare distribution space globally. Its services include inventory management, cold chain packaging and shipping, storage and fulfilment of medical devices, and lab and clinical trial logistics. UPS Healthcare's global infrastructure, its UPS® Premier visibility service, its track and trace technology, and its global quality system are well-suited to meeting today's complex logistics demands for the pharmaceutical, medical device, and laboratory diagnostic industries.
UPS Healthcare and The UPS Foundation facilitate equitable vaccine deliveries
UPS Healthcare to expand its European cold chain capabilities
UPS delivers the first Pfizer-BioNTech COVID-19 vaccines to South Korea